COST-EFFECTIVENESS OF CURRENT THERAPIES IN PRIMARY BILIARY CIRRHOSIS: A SYSTEMATIC REVIEW OF ECONOMIC EVIDENCE

被引:0
|
作者
Pells, G. [1 ]
Jones, D. [1 ]
Vale, L. [1 ]
机构
[1] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
关键词
D O I
10.1136/gutjnl-2015-309861.418
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PTU-304
引用
收藏
页码:A195 / A195
页数:1
相关论文
共 50 条
  • [1] A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies
    Alyson W. Wong
    John Koo
    Christopher J. Ryerson
    Mohsen Sadatsafavi
    Wenjia Chen
    [J]. BMC Pulmonary Medicine, 22
  • [2] A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies
    Wong, Alyson W.
    Koo, John
    Ryerson, Christopher J.
    Sadatsafavi, Mohsen
    Chen, Wenjia
    [J]. BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [3] Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis
    Pasha, T
    Heathcote, J
    Gabriel, S
    Cauch-Dudek, K
    Jorgensen, R
    Therneau, T
    Dickson, ER
    Lindor, KD
    [J]. HEPATOLOGY, 1999, 29 (01) : 21 - 26
  • [4] Cost-effectiveness of ursodeoxycholic acid in primary biliary cirrhosis.
    Pasha, TM
    Heathcote, J
    CauchDudek, K
    Therneau, T
    Dickson, ER
    Gabriel, S
    Lindor, KD
    [J]. HEPATOLOGY, 1996, 24 (04) : 169 - 169
  • [5] Comparative cost-effectiveness of antiviral therapies in patients with chronic hepatitis B: A systematic review of economic evidence
    Sun, Xin
    Qin, Wen-Xia
    Li, You-Ping
    Jiang, Xu-Hua
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (09) : 1369 - 1377
  • [6] The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation
    Loveman, Emma
    Jones, Jeremy
    Clegg, Andrew J.
    Picot, Joanna
    Colquitt, Jillian L.
    Mendes, Diana
    Breen, David J.
    Moore, Emily
    George, Steve
    Poston, Graeme
    Cunningham, David
    Ruers, Theo
    Primrose, John
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2014, 18 (07) : 1 - +
  • [7] A SYSTEMATIC REVIEW OF ECONOMIC EVIDENCE IN HEPATITIS C: AN OVERVIEW OF COST, UTILITY AND COST-EFFECTIVENESS DATA
    Woods, M. S.
    Kiri, S.
    Ling, C.
    McCrink, L.
    Zimovetz, E.
    Hass, B.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A349 - A349
  • [8] Cost-effectiveness analyses of osteoarthritis oral therapies: A systematic review
    Wielage R.C.
    Myers J.A.
    Klein R.W.
    Happich M.
    [J]. Applied Health Economics and Health Policy, 2013, 11 (6) : 593 - 618
  • [9] Cost-effectiveness of complementary therapies in the United Kingdom - A systematic review
    Canter, Peter H.
    Coon, Joanna Thompson
    Ernst, Edzard
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2006, 3 (04) : 425 - 432
  • [10] Cost-effectiveness of targeted oncology therapies: A systematic literature review
    Kalpas, E.
    Doyle, J.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A325 - A326